Innovative’s merger and divestiture of plans expertise enabled us to provide complete end-to-end service for our client during their multi-state, aggressive acquisition strategy. In the end, we were able to consolidate the plans, reduce overall fees by more than 40%, add fiduciary oversight, and ease their administrative burden.
RxDC Reporting Due June 1, 2026
The Centers for Medicare and Medicaid Services (CMS) has updated the Prescription Drug Data Collection (RxDC) resources. The updates include changes to...
Read More